FDA adcomm backs first potential drug for ultra-rare, fatal Barth syndrome – Endpoints News

Heartbreaking anecdotes from patients, parents and doctors of children with the ultra-rare and fatal Barth syndrome won over an FDA advisory committee Thursday…

Sign up to read this article for free.

Get free access to a limited number of articles and opt for newsletters sent directly to your inbox.